API Product   :    Donepezil HCI
CEP   :    -
WCC   :    ?
Therapeutic Use    :    Psychoanaleptics Excluding Anti-Obesity Preparations; Other CNS Drugs
Psychoanaleptics Excluding Anti-Obesity Preparations; Other CNS Drugs
Originator   :    Eisai
CAS No.    :    120014-06-4
Trade Name.   :    ARICEPT
Molecular Weight   :    379.50 g/ mol
379.50 g/ mol
Molecular Formula   :    C24H29NO3
Donepezil is used to treat confusion (dementia) related to Alzheimer's disease. It does not cure Alzheimer's disease, but it may improve memory, awareness, and the ability to function. This medication is an enzyme blocker that works by restoring the balance of natural substances (neurotransmitters) in the brain.
Donepezil, marketed under the trade name Aricept, is a medication used in the palliative treatment of Alzheimer's disease. Donepezil is used to improve cognition and behavior of people with Alzheimer's, but does not slow the progression of or cure the disease. Common side effects include loss of appetite, gastrointestinal upset, diarrhea, difficulty sleeping, vomiting, or muscle cramping. It was developed by Eisai and Pfizer and is sold as a generic by multiple suppliers. Donepezil acts as a centrally acting reversible acetylcholinesterase inhibitor.